These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7280444)

  • 1. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama.
    Sloyer JL; Ploussard JH; Howie VM
    Rev Infect Dis; 1981; 3 Suppl():S119-23. PubMed ID: 7280444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group.
    Teele DW; Klein JO; Bratton L; Fisch GR; Mathieu OR; Porter PJ; Starobin SG; Tarlin LD; Younes RP
    Rev Infect Dis; 1981; 3 Suppl():S113-8. PubMed ID: 7280443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
    Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
    Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.
    Mäkelä PH; Leinonen M; Pukander J; Karma P
    Rev Infect Dis; 1981; 3 Suppl():S124-32. PubMed ID: 6974386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage.
    Wright PF; Sell SH; Vaughn WK; Andrews C; McConnell KB; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S108-12. PubMed ID: 7280442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    Eskola J; Kilpi T; Palmu A; Jokinen J; Haapakoski J; Herva E; Takala A; Käyhty H; Karma P; Kohberger R; Siber G; Mäkelä PH;
    N Engl J Med; 2001 Feb; 344(6):403-9. PubMed ID: 11172176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.
    Black S; Shinefield H; Fireman B; Lewis E; Ray P; Hansen JR; Elvin L; Ensor KM; Hackell J; Siber G; Malinoski F; Madore D; Chang I; Kohberger R; Watson W; Austrian R; Edwards K
    Pediatr Infect Dis J; 2000 Mar; 19(3):187-95. PubMed ID: 10749457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
    Cilveti R; Olmo M; Pérez-Jove J; Picazo JJ; Arimany JL; Mora E; Pérez-Porcuna TM; Aguilar I; Alonso A; Molina F; Del Amo M; Mendez C;
    PLoS One; 2017; 12(2):e0170316. PubMed ID: 28146590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge?
    Pelton SI
    Vaccine; 2000 Dec; 19 Suppl 1():S96-9. PubMed ID: 11163471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of otitis media in children by pneumococcal vaccination.
    Karma P; Pukander J; Sipilä M; Timonen M; Pöntynen S; Herva E; Grönroos P; Mäkelä H
    Am J Otolaryngol; 1985; 6(3):173-84. PubMed ID: 3893185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.
    Veenhoven R; Bogaert D; Uiterwaal C; Brouwer C; Kiezebrink H; Bruin J; IJzerman E; Hermans P; de Groot R; Zegers B; Kuis W; Rijkers G; Schilder A; Sanders E
    Lancet; 2003 Jun; 361(9376):2189-95. PubMed ID: 12842372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.
    Giebink GS; Koskela M; Vella PP; Harris M; Le CT
    J Infect Dis; 1993 Feb; 167(2):347-55. PubMed ID: 8421168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of pneumococcal polysaccharide vaccine in preventing otitis media in infants: different results between racial groups.
    Howie VM; Ploussard J; Sloyer JL; Hill JC
    Pediatrics; 1984 Jan; 73(1):79-81. PubMed ID: 6691045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
    Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccine and otitis media.
    Mäkelä PH; Sibakov M; Herva E; Henrichsen J; Luotonen J; Timonen M; Leinonen M; Koskela M; Pukander J; Pöntynen S; Grönroos P; Karma P
    Lancet; 1980 Sep; 2(8194):547-51. PubMed ID: 6106735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine's effectiveness.
    Ochoa-Gondar O; Figuerola-Massana E; Vila-Corcoles A; Aguirre CA; de Diego C; Satue E; Gomez F; Raga X;
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2104-8. PubMed ID: 26453272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.